pentoxifylline has been researched along with African Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biddle, W | 1 |
| Ambrus, CM | 1 |
| Gastpar, H | 1 |
| Ambrus, JL | 2 |
| Kitabayashi, A | 1 |
| Hirokawa, M | 1 |
| Hatano, Y | 1 |
| Lee, M | 1 |
| Kuroki, J | 1 |
| Niitsu, H | 1 |
| Miura, AB | 1 |
| Aszalos, A | 1 |
| Grimley, PM | 1 |
| Balint, E | 1 |
| Chadha, KC | 1 |
3 other studies available for pentoxifylline and African Lymphoma
| Article | Year |
|---|---|
Antineoplastic effect of the xanthine derivative Trental.
Topics: B-Lymphocytes; Burkitt Lymphoma; Cell Line; Combined Modality Therapy; DNA; Humans; Interferon Type | 1984 |
Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production.
Topics: Antibodies, Monoclonal; Bucladesine; Burkitt Lymphoma; Cyclic AMP; Cytotoxicity, Immunologic; Gene E | 1995 |
On the mechanism of action of interferons: interaction with nonsteroidal anti-inflammatory agents, pentoxifylline (Trental) and cGMP inducers.
Topics: Azides; Burkitt Lymphoma; Cyclic GMP; Drug Interactions; Electron Spin Resonance Spectroscopy; Human | 1991 |